JACOBS LEVY EQUITY MANAGEMENT, INC - SUCAMPO PHARMACEUTICALS INC ownership

SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 131 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SUCAMPO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$315,000
-22.0%
26,670
-27.5%
0.01%
-25.0%
Q2 2016$404,000
-71.5%
36,800
-71.6%
0.01%
-73.3%
Q1 2016$1,418,000
+207.6%
129,690
+458.7%
0.03%
+233.3%
Q3 2015$461,000
+8.7%
23,213
-10.0%
0.01%
+12.5%
Q2 2015$424,000
-12.6%
25,793
-17.3%
0.01%0.0%
Q1 2015$485,000
-12.5%
31,193
-19.6%
0.01%
-11.1%
Q4 2014$554,000
-23.4%
38,802
-61.6%
0.01%
-25.0%
Q1 2014$723,000
+15.3%
101,156
+51.7%
0.01%
+33.3%
Q4 2013$627,000
+9.6%
66,700
-27.2%
0.01%
-10.0%
Q3 2013$572,000
-35.4%
91,600
-32.0%
0.01%
-37.5%
Q2 2013$886,000134,7000.02%
Other shareholders
SUCAMPO PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,304,376$23,414,0007.30%
Kassirer Asset Management Corp 291,784$5,238,0005.39%
First Trust Capital Management L.P. 637,578$11,445,0002.19%
NEXTHERA CAPITAL LP 510,486$9,163,0001.69%
HAVENS ADVISORS LLC 100,000$1,795,0001.35%
Piermont Capital Management Inc. 172,980$3,105,0001.02%
PRELUDE CAPITAL MANAGEMENT, LLC 674,446$12,106,0000.97%
ALPINE ASSOCIATES MANAGEMENT INC. 1,495,600$26,845,0000.96%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$3,590,0000.87%
BOOTHBAY FUND MANAGEMENT, LLC 332,075$5,961,0000.87%
View complete list of SUCAMPO PHARMACEUTICALS INC shareholders